Published in Mol Cell Proteomics on May 18, 2008
Cancer systems biology: a network modeling perspective. Carcinogenesis (2009) 2.22
Outcome of a workshop on applications of protein models in biomedical research. Structure (2009) 2.05
The high-throughput protein sample production platform of the Northeast Structural Genomics Consortium. J Struct Biol (2010) 1.90
Preparation of protein samples for NMR structure, function, and small-molecule screening studies. Methods Enzymol (2011) 1.75
Human cancer protein-protein interaction network: a structural perspective. PLoS Comput Biol (2009) 1.54
The Protein Structure Initiative: achievements and visions for the future. F1000 Biol Rep (2012) 1.38
Assessment of template-based protein structure predictions in CASP10. Proteins (2014) 1.29
The ARID family transcription factor bright is required for both hematopoietic stem cell and B lineage development. Mol Cell Biol (2011) 1.14
Cancer missense mutations alter binding properties of proteins and their interaction networks. PLoS One (2013) 1.14
BioDrugScreen: a computational drug design resource for ranking molecules docked to the human proteome. Nucleic Acids Res (2009) 1.07
The Protein Structure Initiative Structural Biology Knowledgebase Technology Portal: a structural biology web resource. J Struct Funct Genomics (2012) 1.00
Efficient condensed-phase production of perdeuterated soluble and membrane proteins. J Struct Funct Genomics (2010) 0.98
A computational framework for boosting confidence in high-throughput protein-protein interaction datasets. Genome Biol (2012) 0.92
Kinetic rate constant prediction supports the conformational selection mechanism of protein binding. PLoS Comput Biol (2012) 0.89
The structure of vimentin linker 1 and rod 1B domains characterized by site-directed spin-labeling electron paramagnetic resonance (SDSL-EPR) and X-ray crystallography. J Biol Chem (2012) 0.86
iWRAP: An interface threading approach with application to prediction of cancer-related protein-protein interactions. J Mol Biol (2010) 0.86
Docking Small Molecules to Predicted Off-Targets of the Cancer Drug Erlotinib Leads to Inhibitors of Lung Cancer Cell Proliferation with Suitable In vitro Pharmacokinetic Properties. ACS Med Chem Lett (2010) 0.85
Crystal structure of human retinoblastoma binding protein 9. Proteins (2009) 0.84
Engineering of a wheat germ expression system to provide compatibility with a high throughput pET-based cloning platform. J Struct Funct Genomics (2010) 0.83
Constructing the angiome: a global angiogenesis protein interaction network. Physiol Genomics (2012) 0.82
Creating a community resource for protein science. Protein Sci (2012) 0.81
Human cyclin-dependent kinase 2-associated protein 1 (CDK2AP1) is dimeric in its disulfide-reduced state, with natively disordered N-terminal region. J Biol Chem (2012) 0.80
NMR structure of F-actin-binding domain of Arg/Abl2 from Homo sapiens. Proteins (2010) 0.79
Exploring a structural protein-drug interactome for new therapeutics in lung cancer. Mol Biosyst (2014) 0.79
Advances in protein NMR provided by the NIGMS Protein Structure Initiative: impact on drug discovery. Curr Opin Drug Discov Devel (2010) 0.79
Computational tools for the interactive exploration of proteomic and structural data. Mol Cell Proteomics (2010) 0.79
Communication routes in ARID domains between distal residues in helix 5 and the DNA-binding loops. PLoS Comput Biol (2014) 0.79
Solution NMR structure of the ARID domain of human AT-rich interactive domain-containing protein 3A: a human cancer protein interaction network target. Proteins (2010) 0.77
Overexpression of the catalytically impaired Taspase1 T234V or Taspase1 D233A variants does not have a dominant negative effect in T(4;11) leukemia cells. PLoS One (2012) 0.76
Solution NMR structures of homeodomains from human proteins ALX4, ZHX1, and CASP8AP2 contribute to the structural coverage of the Human Cancer Protein Interaction Network. J Struct Funct Genomics (2014) 0.76
The RAS-Binding Domain of Human BRAF Protein Serine/Threonine Kinase Exhibits Allosteric Conformational Changes upon Binding HRAS. Structure (2015) 0.75
pathDIP: an annotated resource for known and predicted human gene-pathway associations and pathway enrichment analysis. Nucleic Acids Res (2016) 0.75
Solution structure of the free Zα domain of human DLM-1 (ZBP1/DAI), a Z-DNA binding domain. J Biomol NMR (2014) 0.75
Polypeptide backbone, C(β) and methyl group resonance assignments of the 24 kDa plectin repeat domain 6 from human protein plectin. Biomol NMR Assign (2014) 0.75
Solution NMR structures of immunoglobulin-like domains 7 and 12 from obscurin-like protein 1 contribute to the structural coverage of the Human Cancer Protein Interaction Network. J Struct Funct Genomics (2014) 0.75
Human retinoblastoma binding protein 9, a serine hydrolase implicated in pancreatic cancers. Protein Pept Lett (2012) 0.75
Quantification of the impact of PSI:Biology according to the annotations of the determined structures. BMC Struct Biol (2013) 0.75
Computational large-scale mapping of protein-protein interactions using structural complexes. Curr Protoc Protein Sci (2013) 0.75
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
The sequence of the human genome. Science (2001) 101.55
Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol (2001) 66.87
The Pfam protein families database. Nucleic Acids Res (2004) 56.46
Improved prediction of signal peptides: SignalP 3.0. J Mol Biol (2004) 48.40
Finishing the euchromatic sequence of the human genome. Nature (2004) 41.40
KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res (1999) 40.62
Patterns of somatic mutation in human cancer genomes. Nature (2007) 38.41
Predicting coiled coils from protein sequences. Science (1991) 38.18
Network biology: understanding the cell's functional organization. Nat Rev Genet (2004) 36.62
A census of human cancer genes. Nat Rev Cancer (2004) 36.20
Pfam: clans, web tools and services. Nucleic Acids Res (2006) 34.83
Structure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins (2003) 32.38
Lethality and centrality in protein networks. Nature (2001) 29.64
Protein structure alignment by incremental combinatorial extension (CE) of the optimal path. Protein Eng (1998) 28.09
Towards a proteome-scale map of the human protein-protein interaction network. Nature (2005) 24.76
Cancer genes and the pathways they control. Nat Med (2004) 24.22
The Universal Protein Resource (UniProt): an expanding universe of protein information. Nucleic Acids Res (2006) 22.70
Hierarchical organization of modularity in metabolic networks. Science (2002) 22.47
Reactome: a knowledgebase of biological pathways. Nucleic Acids Res (2005) 20.05
A human protein-protein interaction network: a resource for annotating the proteome. Cell (2005) 18.97
The Gene Ontology Annotation (GOA) Database: sharing knowledge in Uniprot with Gene Ontology. Nucleic Acids Res (2004) 18.75
Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct (2000) 17.81
MINT: a Molecular INTeraction database. FEBS Lett (2002) 17.21
Analysis of compositionally biased regions in sequence databases. Methods Enzymol (1996) 17.11
DIP, the Database of Interacting Proteins: a research tool for studying cellular networks of protein interactions. Nucleic Acids Res (2002) 15.70
Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Res (2003) 14.79
The International Protein Index: an integrated database for proteomics experiments. Proteomics (2004) 14.67
Mapping the protein universe. Science (1996) 13.72
Assessment of protein models with three-dimensional profiles. Nature (1992) 12.64
Protein structure prediction and structural genomics. Science (2001) 11.76
Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J Mol Biol (1999) 11.38
Recognition of errors in three-dimensional structures of proteins. Proteins (1993) 9.38
A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell (2006) 8.61
Intrinsic disorder and protein function. Biochemistry (2002) 8.54
Why are "natively unfolded" proteins unstructured under physiologic conditions? Proteins (2000) 7.61
Toward the structural genomics of complexes: crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2006) 7.29
EGASP: the human ENCODE Genome Annotation Assessment Project. Genome Biol (2006) 7.06
Online predicted human interaction database. Bioinformatics (2005) 6.83
Coupling of folding and binding for unstructured proteins. Curr Opin Struct Biol (2002) 6.53
Pathguide: a pathway resource list. Nucleic Acids Res (2006) 6.05
Intrinsic disorder in cell-signaling and cancer-associated proteins. J Mol Biol (2002) 5.64
The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics. PLoS Comput Biol (2007) 5.63
Evaluating protein structures determined by structural genomics consortia. Proteins (2007) 5.45
The impact of structural genomics: expectations and outcomes. Science (2006) 5.30
High-throughput mapping of a dynamic signaling network in mammalian cells. Science (2005) 5.21
High-quality protein knowledge resource: SWISS-PROT and TrEMBL. Brief Bioinform (2002) 4.95
Functional and topological characterization of protein interaction networks. Proteomics (2004) 4.57
Probabilistic model of the human protein-protein interaction network. Nat Biotechnol (2005) 3.99
The interplay between structure and function in intrinsically unstructured proteins. FEBS Lett (2005) 3.80
Comparative genomics of centrality and essentiality in three eukaryotic protein-interaction networks. Mol Biol Evol (2004) 3.73
MODBASE: a database of annotated comparative protein structure models and associated resources. Nucleic Acids Res (2006) 3.56
Attack vulnerability of complex networks. Phys Rev E Stat Nonlin Soft Matter Phys (2002) 3.54
A tour of structural genomics. Nat Rev Genet (2001) 3.18
Complexity in biological signaling systems. Science (1999) 3.05
Pathway information for systems biology. FEBS Lett (2005) 2.97
An integrated approach to the analysis and modeling of protein sequences and structures. I. Protein structural alignment and a quantitative measure for protein structural distance. J Mol Biol (2000) 2.79
High-betweenness proteins in the yeast protein interaction network. J Biomed Biotechnol (2005) 2.44
Automatic target selection for structural genomics on eukaryotes. Proteins (2004) 2.34
Cancer: a Systems Biology disease. Biosystems (2006) 2.29
Functional coverage of the human genome by existing structures, structural genomics targets, and homology models. PLoS Comput Biol (2005) 2.04
Implications of structural genomics target selection strategies: Pfam5000, whole genome, and random approaches. Proteins (2005) 1.71
Small molecules, big players: the National Cancer Institute's Initiative for Chemical Genetics. Cancer Res (2006) 1.51
Addressing the intrinsic disorder bottleneck in structural proteomics. Proteins (2005) 1.44
Chemical genetics to chemical genomics: small molecules offer big insights. Chem Soc Rev (2005) 1.44
The TB structural genomics consortium: providing a structural foundation for drug discovery. Curr Drug Targets Infect Disord (2002) 1.28
Analysis and comparison of metabolic pathway databases. Brief Bioinform (2001) 1.26
Comparing classical pathways and modern networks: towards the development of an edge ontology. Trends Biochem Sci (2007) 1.23
Analysing differential gene expression in cancer. Nat Rev Cancer (2003) 1.13
Oncogenomics and the development of new cancer therapies. Nature (2004) 1.06
Structural genomics of proteins from conserved biochemical pathways and processes. Curr Opin Struct Biol (2002) 1.03
Assessing model accuracy using the homology modeling automatically software. Proteins (2008) 1.01
Genomic and proteomic technologies for individualisation and improvement of cancer treatment. Eur J Cancer (2004) 0.94
Structural genomics of microbes: an objective. Curr Opin Struct Biol (2000) 0.93
A unified representation of multiprotein complex data for modeling interaction networks. Proteins (2004) 0.91
Combining structural genomics and enzymology: completing the picture in metabolic pathways and enzyme active sites. Curr Opin Struct Biol (2000) 0.91
Target selection for complex structural genomics. Curr Opin Struct Biol (2006) 0.90
Protein therapeutics: promises and challenges for the 21st century. Trends Biotechnol (2002) 0.81
Genetics, genomics, and drug discovery. Med Res Rev (2000) 0.79
Structural genomics in pharmaceutical design. J Struct Funct Genomics (2002) 0.77
Contribution of structural genomics to understanding the biology of Escherichia coli. J Bacteriol (2003) 0.77
Paired-end mapping reveals extensive structural variation in the human genome. Science (2007) 30.46
The genomic complexity of primary human prostate cancer. Nature (2011) 14.06
Mapping copy number variation by population-scale genome sequencing. Nature (2011) 12.55
A systematic survey of loss-of-function variants in human protein-coding genes. Science (2012) 12.25
Unlocking the secrets of the genome. Nature (2009) 11.80
PeakSeq enables systematic scoring of ChIP-seq experiments relative to controls. Nat Biotechnol (2009) 11.28
Variation in transcription factor binding among humans. Science (2010) 9.33
Consistent blind protein structure generation from NMR chemical shift data. Proc Natl Acad Sci U S A (2008) 6.76
Performance comparison of whole-genome sequencing platforms. Nat Biotechnol (2011) 5.79
Relating three-dimensional structures to protein networks provides evolutionary insights. Science (2006) 5.50
Evaluating protein structures determined by structural genomics consortia. Proteins (2007) 5.45
Nucleotide-resolution analysis of structural variants using BreakSeq and a breakpoint library. Nat Biotechnol (2009) 5.13
High-resolution mapping of DNA copy alterations in human chromosome 22 using high-density tiling oligonucleotide arrays. Proc Natl Acad Sci U S A (2006) 4.84
Mapping of transcription factor binding regions in mammalian cells by ChIP: comparison of array- and sequencing-based technologies. Genome Res (2007) 4.59
Assessment of whole genome amplification-induced bias through high-throughput, massively parallel whole genome sequencing. BMC Genomics (2006) 4.55
Protein NMR recall, precision, and F-measure scores (RPF scores): structure quality assessment measures based on information retrieval statistics. J Am Chem Soc (2005) 4.43
PEMer: a computational framework with simulation-based error models for inferring genomic structural variants from massive paired-end sequencing data. Genome Biol (2009) 4.18
The GENCODE pseudogene resource. Genome Biol (2012) 4.18
Protein production and purification. Nat Methods (2008) 3.97
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site. Nat Struct Biol (2002) 3.92
An integrated approach for finding overlooked genes in yeast. Nat Biotechnol (2002) 3.88
Pseudogenes in the ENCODE regions: consensus annotation, analysis of transcription, and evolution. Genome Res (2007) 3.82
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets. Cancer Discov (2011) 3.43
The reality of pervasive transcription. PLoS Biol (2011) 3.41
Systematic prediction and validation of breakpoints associated with copy-number variants in the human genome. Proc Natl Acad Sci U S A (2007) 3.35
Distinct genomic aberrations associated with ERG rearranged prostate cancer. Genes Chromosomes Cancer (2009) 3.03
NMR structure determination for larger proteins using backbone-only data. Science (2010) 3.00
Deciphering protein kinase specificity through large-scale analysis of yeast phosphorylation site motifs. Sci Signal (2010) 2.95
Polyadenylation factor CPSF-73 is the pre-mRNA 3'-end-processing endonuclease. Nature (2006) 2.95
PubNet: a flexible system for visualizing literature derived networks. Genome Biol (2005) 2.89
Quantifying environmental adaptation of metabolic pathways in metagenomics. Proc Natl Acad Sci U S A (2009) 2.89
FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data. Genome Biol (2010) 2.79
Structured RNAs in the ENCODE selected regions of the human genome. Genome Res (2007) 2.69
Cold-shock induced high-yield protein production in Escherichia coli. Nat Biotechnol (2004) 2.62
Publishing perishing? Towards tomorrow's information architecture. BMC Bioinformatics (2007) 2.55
Positive selection at the protein network periphery: evaluation in terms of structural constraints and cellular context. Proc Natl Acad Sci U S A (2007) 2.55
Robotic cloning and Protein Production Platform of the Northeast Structural Genomics Consortium. Methods Enzymol (2005) 2.54
CASD-NMR: critical assessment of automated structure determination by NMR. Nat Methods (2009) 2.50
Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing. Genome Res (2010) 2.50
Principles for designing ideal protein structures. Nature (2012) 2.50
Molecular sampling of prostate cancer: a dilemma for predicting disease progression. BMC Med Genomics (2010) 2.40
Mechanism of activation for transcription factor PhoB suggested by different modes of dimerization in the inactive and active states. Structure (2005) 2.39
Toward a universal microarray: prediction of gene expression through nearest-neighbor probe sequence identification. Nucleic Acids Res (2007) 2.39
UNC119 is required for G protein trafficking in sensory neurons. Nat Neurosci (2011) 2.38
Diverse roles and interactions of the SWI/SNF chromatin remodeling complex revealed using global approaches. PLoS Genet (2011) 2.38
Structural basis of the alpha1-beta subunit interaction of voltage-gated Ca2+ channels. Nature (2004) 2.38
Annotating non-coding regions of the genome. Nat Rev Genet (2010) 2.38
The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies. Proc Natl Acad Sci U S A (2009) 2.36
Reduced-dimensionality NMR spectroscopy for high-throughput protein resonance assignment. Proc Natl Acad Sci U S A (2002) 2.36
Automatic target selection for structural genomics on eukaryotes. Proteins (2004) 2.34
Outcome of a workshop on archiving structural models of biological macromolecules. Structure (2006) 2.32
The protein target list of the Northeast Structural Genomics Consortium. Proteins (2004) 2.31
The real cost of sequencing: higher than you think! Genome Biol (2011) 2.22
Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents. Nat Struct Mol Biol (2006) 2.21
A myelopoiesis-associated regulatory intergenic noncoding RNA transcript within the human HOXA cluster. Blood (2009) 2.18
Analysis of copy number variants and segmental duplications in the human genome: Evidence for a change in the process of formation in recent evolutionary history. Genome Res (2008) 2.17
Crystal structure of human DJ-1, a protein associated with early onset Parkinson's disease. J Biol Chem (2003) 2.15
NMR data collection and analysis protocol for high-throughput protein structure determination. Proc Natl Acad Sci U S A (2005) 2.09
Assessing the need for sequence-based normalization in tiling microarray experiments. Bioinformatics (2007) 2.08
Outcome of a workshop on applications of protein models in biomedical research. Structure (2009) 2.05
Statistical analysis of the genomic distribution and correlation of regulatory elements in the ENCODE regions. Genome Res (2007) 2.03
Structural basis for suppression of a host antiviral response by influenza A virus. Proc Natl Acad Sci U S A (2008) 2.02
Assessing the performance of different high-density tiling microarray strategies for mapping transcribed regions of the human genome. Genome Res (2006) 1.95
Assignment validation software suite for the evaluation and presentation of protein resonance assignment data. J Biomol NMR (2004) 1.95
Crystal structure of the heterotrimer core of Saccharomyces cerevisiae AMPK homologue SNF1. Nature (2007) 1.94
Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis. PLoS Comput Biol (2010) 1.92
The high-throughput protein sample production platform of the Northeast Structural Genomics Consortium. J Struct Biol (2010) 1.90
Structural and molecular basis of the assembly of the TRPP2/PKD1 complex. Proc Natl Acad Sci U S A (2009) 1.84
Structure and function of the 5'-->3' exoribonuclease Rat1 and its activating partner Rai1. Nature (2009) 1.83
Determination of solution structures of proteins up to 40 kDa using CS-Rosetta with sparse NMR data from deuterated samples. Proc Natl Acad Sci U S A (2012) 1.83
Integrated analysis of experimental data sets reveals many novel promoters in 1% of the human genome. Genome Res (2007) 1.82
Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma. Sci Transl Med (2011) 1.79
A topology-constrained distance network algorithm for protein structure determination from NOESY data. Proteins (2006) 1.79
Understanding the physical properties that control protein crystallization by analysis of large-scale experimental data. Nat Biotechnol (2009) 1.78
Bayesian modeling of the yeast SH3 domain interactome predicts spatiotemporal dynamics of endocytosis proteins. PLoS Biol (2009) 1.78
Solution NMR structure of the iron-sulfur cluster assembly protein U (IscU) with zinc bound at the active site. J Mol Biol (2004) 1.76
Preparation of protein samples for NMR structure, function, and small-molecule screening studies. Methods Enzymol (2011) 1.75
A computational approach for identifying pseudogenes in the ENCODE regions. Genome Biol (2006) 1.74
Structural and biochemical studies identify tobacco SABP2 as a methyl salicylate esterase and implicate it in plant innate immunity. Proc Natl Acad Sci U S A (2005) 1.73
Biophysical characterization of the complex between double-stranded RNA and the N-terminal domain of the NS1 protein from influenza A virus: evidence for a novel RNA-binding mode. Biochemistry (2004) 1.72
Detecting and annotating genetic variations using the HugeSeq pipeline. Nat Biotechnol (2012) 1.72
N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer. Neoplasia (2009) 1.68
A de novo protein binding pair by computational design and directed evolution. Mol Cell (2011) 1.65
Crystal structure of the carboxyltransferase domain of acetyl-coenzyme A carboxylase. Science (2003) 1.63
High-resolution copy-number variation map reflects human olfactory receptor diversity and evolution. PLoS Genet (2008) 1.60
Identification of a quality-control mechanism for mRNA 5'-end capping. Nature (2010) 1.58
Crystal structure of the human symplekin-Ssu72-CTD phosphopeptide complex. Nature (2010) 1.58
The ambiguous boundary between genes and pseudogenes: the dead rise up, or do they? Trends Genet (2007) 1.57
Novel leverage of structural genomics. Nat Biotechnol (2007) 1.57
Mining the structural genomics pipeline: identification of protein properties that affect high-throughput experimental analysis. J Mol Biol (2004) 1.57
Chromatin state signatures associated with tissue-specific gene expression and enhancer activity in the embryonic limb. Genome Res (2012) 1.57
The DART classification of unannotated transcription within the ENCODE regions: associating transcription with known and novel loci. Genome Res (2007) 1.56
Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate. J Med Chem (2002) 1.56
Bacterial neuraminidase facilitates mucosal infection by participating in biofilm production. J Clin Invest (2006) 1.54
Optimal alignment for enzymatic proton transfer: structure of the Michaelis complex of triosephosphate isomerase at 1.2-A resolution. Proc Natl Acad Sci U S A (2002) 1.53
Crystal structure of 1-deoxy-D-xylulose 5-phosphate synthase, a crucial enzyme for isoprenoids biosynthesis. J Biol Chem (2006) 1.53
Solution NMR structure of the junction between tropomyosin molecules: implications for actin binding and regulation. J Mol Biol (2006) 1.52